Fig. 6: Immune cell recruitment at defect sites administered PEG MAP + BMP-2 treatment was influenced by PEG sensitization at the 3- and 6-week timepoints, as well as by biological sex at the 6-week timepoint. | Nature Communications

Fig. 6: Immune cell recruitment at defect sites administered PEG MAP + BMP-2 treatment was influenced by PEG sensitization at the 3- and 6-week timepoints, as well as by biological sex at the 6-week timepoint.

From: Impact of PEG sensitization on the efficacy of PEG hydrogel-mediated tissue engineering

Fig. 6

Quantification of A CD68+ cells and B CD3+ cells at defect sites 3 and 6 weeks post-implantation. Statistical significance was calculated by ordinary two-way ANOVA with Tukey’s multiple comparisons test with a single pooled variance, an alpha threshold of 0.05, and 95% confidence interval. Center line = median; box limits = upper and lower quartiles; whiskers = 1.5× interquartile range (n = 4 mice per treatment group). Staining is representative of n = 4 sections per sample. Scale bar = 60 µm.

Back to article page